EUVIMEDEUVIMED entdecken
Crossref

Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS

Melissa L Johnson iD

Journal of Clinical Oncology · 20.06.2026 · 44 (18) · 1748-1749

DOI: 10.1200/jco-26-00311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Oncology, erschienen am 20.06.2026. Verfasst von Melissa L Johnson. Beteiligte Einrichtung: Melissa L. Johnson, MD, Sarah Cannon Research Institute, Nashville, TN. Die Arbeit nennt 11 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Melissa L. Johnson, MD, Sarah Cannon Research Institute, Nashville, TN.

ORCID-Profile: Melissa L Johnson

Zitieren

APA

Johnson, M. L. (2026). Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology, 44(18), 1748-1749. https://doi.org/10.1200/jco-26-00311

Vancouver

Johnson ML. Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS. Journal of Clinical Oncology. 2026;44(18):1748-1749. doi:10.1200/jco-26-00311

BibTeX
@article{Johnson2026,
  author = {Johnson, Melissa L},
  title = {Reply to: Treatment Switching and Subsequent Therapy Confound Overall Survival Estimates in PHAROS},
  journal = {Journal of Clinical Oncology},
  year = {2026},
  volume = {44},
  number = {18},
  pages = {1748--1749},
  doi = {10.1200/jco-26-00311}
}
Kostenlos starten →